Low-Clarke V, Repole-Li Vaccari A, Barakat-Johnson M, et al.
Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy an.... Date of publication 2025 Jul 1;volume 52(4):330-335.
1. J Wound Ostomy Continence Nurs. 2025 Jul-Aug 01;52(4):330-335. doi:
10.1097/WON.0000000000001189. Epub 2025 Jul 24.
Treatment of Severe Incontinence-Associated Dermatitis Using Polymer
Cyanoacrylate: A Report on Three Case Studies.
Low-Clarke V(1)(2)(3), Repole-Li Vaccari A(1)(2)(3), Barakat-Johnson M(1)(2)(3).
Author information:
(1)Vivien Low-Clarke, MN, BSc, RN, Royal Prince Alfred Hospital, Sydney Local
Health District and Susan Wakil School of Nursing and Midwifery, Faculty of
Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.
(2)Apryl Repole-Li Vaccari, BN, RN, Royal Prince Alfred Hospital, Sydney Local
Health District and Susan Wakil School of Nursing and Midwifery, Faculty of
Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.
(3)Michelle Barakat-Johnson, BN, MN, PhD, Sydney Local Health District and Susan
Wakil School of Nursing and Midwifery, Faculty of Medicine and Health, The
University of Sydney, Camperdown, NSW, Australia, and School of Social Sciences,
University of Huddersfield, Huddersfield, UK.
BACKGROUND: Incontinence-associated dermatitis (IAD) is a painful skin condition
resulting from prolonged exposure to moisture, friction, and irritants found in
urine and feces. Category 2 IAD involves partial-thickness skin loss with open
lesions, causing severe pain due to exposed nerve endings. Effective management
in clinical settings is vital to alleviate discomfort and prevent secondary
infections, though treatment options for severe IAD remain is limited despite
its occurrence.
CASES: We report the successful management of Category 2 IAD involving the
dermis and subcutaneous layers in 3 patients using a polymer cyanoacrylate. This
intervention provided a protective barrier, shielding the skin from moisture and
irritants while promoting healing. All patients exhibited significant
improvement in skin condition and reported reduced pain within weeks of
initiating treatment.
CONCLUSION: Each case demonstrated improvement in IAD, wound healing, and
reduced pain. These case studies aim to inform clinicians about the potential
benefits of polymer cyanoacrylate in the management of severe IAD.
Copyright © 2025 by the Wound, Ostomy, and Continence Nurses Society.
DOI: 10.1097/WON.0000000000001189
PMID: 40717262 [Indexed for MEDLINE]
